Cas:4055-69-0 2,3-dihydroxy-4-methoxybenzaldehyde manufacturer & supplier

We serve Chemical Name:2,3-dihydroxy-4-methoxybenzaldehyde CAS:4055-69-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,3-dihydroxy-4-methoxybenzaldehyde

Chemical Name:2,3-dihydroxy-4-methoxybenzaldehyde
CAS.NO:4055-69-0
Synonyms:Benzaldehyde,2,3-dihydroxy-4-methoxy;2,3-dihydroxy4-methoxy-benzaldehyde;3-hydroxy-4-methoxysalicylaldehyde;2,3-Dihydroxy-4-methoxy-benzaldehyd
Molecular Formula:C8H8O4
Molecular Weight:168.14700
HS Code:2912499000

Physical and Chemical Properties:
Melting point:N/A
Boiling point:299ºC at 760mmHg
Density:1.378g/cm3
Index of Refraction:1.631
PSA:66.76000
Exact Mass:168.04200
LogP:0.91890

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzaldehyde,2,3-dihydroxy-4-methoxy chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-Dihydroxy-4-methoxy-benzaldehyd physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-dihydroxy4-methoxy-benzaldehyde Use and application,Benzaldehyde,2,3-dihydroxy-4-methoxy technical grade,usp/ep/jp grade.


Related News: This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment, Mankind Pharma Director of Marketing Sanjay Koul said in a statement. 2,3-dihydroxy-4-methoxybenzaldehyde manufacturer He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 2,3-dihydroxy-4-methoxybenzaldehyde supplier In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. . 2,3-dihydroxy-4-methoxybenzaldehyde vendor He said the FDA made its decision by fiat, and had not asked its advisors to consider whether the drug’s ability to remove a type of brain plaques known as beta amyloid would improve outcomes for patients. 2,3-dihydroxy-4-methoxybenzaldehyde factory In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .